Efficacy of bevacizumab combined with erlotinib for advanced hepatocellular carcinoma: a single-arm meta-analysis based on prospective studies

BACKGROUND: The efficacy of bevacizumab combined with erlotinib (B + E) for the treatment of advanced hepatocellular carcinoma, especially for sorafenib-refractory patients, has been observed and evaluated in several trials. We conducted this single arm meta-analysis to generally assess the benefit...

Descripción completa

Detalles Bibliográficos
Autores principales: He, Liyun, Deng, Huan, Lei, Jun, Yi, Fengming, Li, Jine, Fan, Xiu De, Wei, Yiping, Xu, Jianjun, Zhang, Wenxiong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6437948/
https://www.ncbi.nlm.nih.gov/pubmed/30922256
http://dx.doi.org/10.1186/s12885-019-5487-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6437948/
https://www.ncbi.nlm.nih.gov/pubmed/30922256
http://dx.doi.org/10.1186/s12885-019-5487-6

Ejemplares similares